VC-2 vaccine confers protection against viral ocular immunopathogenesis through T-cell infiltration Jan. 3, 2022
Bovine/human parainfluenza virus 3 vector SARS-CoV-2 vaccine shows promise in hamster model Dec. 30, 2021